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1. Introduction 
The early teaching used to be “Eat when you can, sleep when you can and don’t operate on 
the pancreas”. Also the belief was that God put the pancreas at the back because He did not 
want surgeons messing with it. It was Rufus of Ephesus (c. 100AD) who named the organ 
‘‘Pancreas’’ (in Greek Pan: all, Kreas: Flesh or meat). Then it was Homer who used the word 
‘sweetbread’’ broadly to describe animal flesh (Modilin IM et al. Int Hepato-pancreato-
biliary association, Indian Chapter, single theme conference; 2002; 1-3:32-46). This organ 
with the name sweetbread, however, turns quite bitter as soon it develops the pathological 
condition called chronic pancreatitis. H. Durmen has summarized the anatomical 
relationship of the pancreas as: “The pancreas cuddles the left kidney, tickles the spleen, 
hugs the duodenum, cradles the aorta, opposes the inferior vena cava, dallies with the right 
renal pedicle, hides behind the posterior parietal peritoneum of the lesser sac and wraps 
itself around the superior mesenteric vessels”(Dionigi R et al). It derives its blood supply 
from major branches of the celiac and superior mesenteric arteries and it is mandatory for 
any surgeon operating on the pancreas to develop understanding of its vascular anatomy 
and its possible variations. 
Chronic pancreatitis has been defined as a continuing inflammatory disease of the pancreas 
characterized by irreversible morphologic changes that typically cause pain and or 
permanent loss of function (Clain JE, Pearson RK. Surg Clinc North Am 1999;79:829-46). An 
ideal classification system for chronic pancreatitis would be simple, objective, accurate, 
incorporating etiology, pathogenesis, structure, function and clinical status into one overall 
scheme. Although these criteria have never been met, several systems have been advocated. 
The most widely used classification systems include Marseille classification of 1963 (Sarles 
H.Symposium of Marseille 1963. Besel),with revisions in 1984 and 1987 and the Cambridge 
classification of 1984 (Sarner M and Cotton PB. Gut 1984;24:756-9). The Cambridge system 
proves more useful as a staging system once the diagnosis has been established. The 
Marseille-Rome classification 1987 includes more causal factors but proves to be more useful 
in defining pancreatitis. The numbers have increased markedly probably due to the changes 
in alcohol consumption and improved sensitivity of diagnostic tests. Early series from 
Copenhagen (Copenhagen pancreatitis study. Scand J Gastroenterol 1981;16:305-12), the 
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U.S.(Reila A et al. Mayo clin Proc 1992;67:839-45) and Mexico City(Robles-Diaz G et al; 
Pancreas 1990;5:479-83) reported a similar incidence of about 4 per 100,000 inhabitants per 
year and prevalence rate of 45.5 per 100,000 in males and 12.4 per 100,000 in females 
(Charles S T, Singer MV. Scand J Gastrenterol 2003; 35:136-41). Recent advances in 
techniques and genetics provide possibilities for early and accurate identification of risk 
factors leading to chronic pancreatitis. Chronic pancreatitis has been categorized into toxic, 
idiopathic, genetic, autoimmune, recurrent attacks of acute pancreatitis and obstructive 
(TIGAR-O risk factor classification system version 1). The classification is based on 
prevalence of each etiological factor and has implications for potential treatment. 
2. Pathogenesis  
The hallmark of chronic pancreatitis is the replacement of normal pancreatic tissue with 
fibrotic tissue. This change leads to mass formation, ductal obstruction, and encasement of 
other structures or some combination of the above (Amman RW et al. Gastroenterology 
1984; 86:820-8).The mechanism by which fibrosis takes place is incompletely understood but 
several advances have been made in the last several years. Ethanol in alcohol or its 
metabolites are believed to have a direct toxic effect on the pancreas and contribute to the 
development of chronic pancreatitis (Levy P et al. Pancreas 1995; 10:231-8). Ethanol seems to 
stimulate Pancreatic stellate cells (PSCs) through its metabolite acetaldehyde. PSCs regulate 
extracellular matrix proteins within the pancreas and collagen deposition within the gland. 
PSCs also in response to and production of various cytokines results in a self-sustaining 
cycle of inflammation and fibrosis (Apte MV,Wilson JS. Pancreas 2003; 27:316-20). Pancretic 
stone protein (PSP), or lithostathine, is also effected by ethanol and may be over or 
underproduced in patients of chronic pancreatitis.The role of PSP is to stabilize inorganic 
ion complexes and to prevent precipitation of calcium carbonate (Bernard JP et al. 
Gastroenterology 1992; 103:1277-84). Alterations in PSP productions can lead to protein 
plugs or pancreatic duct stones which in turn can lead to ductal obstruction, intraductal and 
parenchymal hypertension, and subsequent continued cellular and organ damage. Many 
people over- consume ethanol and still do not develop the disease in contrary to those who 
consume very little and still develop the disease. The most likely explanation for this is that 
some patients are born with or develop a genetic predisposition and get the disease by a 
multistep complex pathway. Several genetic aberrancies have been well implicated like 
PRSS1, SPINK1, and CFTR and are considered to be most notable for the development of 
chronic pancreatitis.PRSS1 is involved in trypsin metabolism and regulation of the conversion 
of pro-pancreatic enzymes to their active form. SPINK1 inhibits intrapancreatic trypsin 
function to help autodigestion. The cystic fibrosis transcription repair (CFTR) gene is an 
essential gene for the proper regulation of pancreatic fluid, calcium and bicarbonate secretion.  
Regulation of bicarbonate also effects the inactive versus active forms of trypsin. The net effect 
of all these processes is chronic injury to the parenchyma of the pancreas with subsequent 
fibrosis and collagen deposition. Although this accounts, at least in part, for the mass effect in 
some patients and for the intraductal and glandular hypertension but may not completely 
explain why some patients have pain syndromes and others do not. The pathogenesis of pain 
is almost certainly linked in some degree to the already mentioned facts but still some patients 
have the disease without any mass effect or any evidence of ductal obstruction (Martin RF and 
Marion MD. Surg Clinic N Am 2007; 87:1461-1475). 
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Medical management which consists of enzyme replacement, control of diabetes with 
insulin and oral analgesics is generally effective, although eventually one third of the 
patients will need surgery during the course of their disease. The surgical management of 
pancreatitis has seen its ups and downs over the past few decades. 
The risks of pancreatic surgery were initially high but a few surgeons were bold enough to 
approach the chronically inflamed and enlarged pancreas. A number of surgical procedures 
have been developed during the 20th century to deal with the condition. Review of 
literature indicates the maximum efficacy of any procedure to be 85 to 90%. There is no 
procedure evolved to provide a 100% cure for the condition. (Udani PM et al 
<http/bhjorg/journal/1999:4102>) 
Dr. Kenneth Warren reported in 1959 that operations for chronic pancreatitis failed when 
they were not chosen on the basis of pathology observed at the time of operation and all 
operations were not successful all the time. His statements hold true even for present time 
(Warren KW. Gastroenterology 1959; 36:224-31). Therefore, surgery is aimed at controlling 
pain and managing complications rather than halting the progression of the disease. An 
appropriate and effective procedure has been difficult to devise and at the moment there is 
no clear ‘‘market leader’’ operation and the choice depends up on a grey zone where in 
pathological picture, patient’s condition and available expertise dictate the final procedure 
the patient undergoes. The trends in choice of operation have not solely been based on 
better capacity to match the operation with the pathology discovered in the patient but also 
with the global level of comfort with the operations being performed. The ideal procedure 
for treating pain in chronic pancreatitis should be the one which is simple, easy to perform, 
associated with low morbidity and mortality, and at the same time should provide adequate 
drainage and not augment endocrine and exocrine insufficiency. 
3. Indications for surgical intervention 
Currently the following are considered the acceptable indications for surgery (Knoeful WT 
et al. Panceratology 2002; 2:379-85). 
1. Intractable pain. 
2. Suspicion of malignant neoplasm. 
3. Non-resolving ductal stenosis. 
4. Non-resolving common bile duct stenosis. 
5. Pseudo-aneurysms or vascular erosions not controlled by radiological intervention. 
6. Endoscopically not controlled large pseudopancreatic cyst. 
7. Intractable internal pancreatic fistula. 
4. Preoperative evaluation and patient selection 
Once a patient has been selected to undergo surgery for pain relief, a thorough preoperative 
evaluation must be performed. Two important questions must be answered. 
1. Will this patient benefit most from a decompression of the pancreatic ductal system or 
from resection of pancreas? 
2. Is this patient harboring a pancreatic malignancy? 
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The various biochemical and radiological tests for preoperative assessment and diagnosis 
are as follows. 
4.1 Blood tests 
Elevations of serum amylase and lipase are found helpful during acute attacks of pain. In 
the later stages chronic pancreatitis atrophy of the pancreatic parenchyma can result in 
serum enzyme levels within the reference range, even during acute exacerbations. 
While low levels of serum trypsin are specific for advanced chronic pancreatitis, they are not 
sensitive enough to be helpful in most patients with mild to moderate disease.(Yashke P-e 
medicine) 
Laboratory studies to identify causative factors include serum calcium and triglyceride 
levels. 
4.2 Fecal tests 
Steatorrhoea may be present in advanced chronic pancreatitis but neither qualitative nor 
quantitative fecal fat analysis can detect early disease. 
4.3 Direct tests 
Tests to detect chronic pancreatitis early are invasive and expensive. 
4.3.1 Determination of duodenal aspirates 
Pancreatic secretions are stimulated by exogenous secretion to achieve maximal output. The 
bicarbonate, protease, amylase and lipase output is then measured in the duodenal 
aspirates. This test is, however, only available in specialized centers. 
4.3.2 Determination in pancreatic juice 
This test is performed at the time of endoscopic retrograde pancreatography (ERCP). The 
pancreatic duct is freely cannulated, an external secretagogue is administered and the 
pancreatic juice is then aspirated out of the duct as it is produced. The bicarbonate, protease, 
amylase and lipase output is then measured. This test is gaining popularity because most 
patients undergo ERCP during the evaluation of chronic pancreatitis. 
4.4 Indirect test 
Non-invasive tests in principle work via oral administration of a complex substance that is 
hydrolyzed by a specific pancreatic enzyme to release a marker substance. The marker is 
then absorbed by the intestine and in turn measured in the serum or urine. These tests are 
capable of detecting moderate to severe degrees of chronic pancreatitis. Liver, renal and 
intestinal disease may interfere with the interpretation of these tests. They are not freely 
available in the United States (Yashke P e-medicine; Laukoisch PG. Int J Pancreatol 1993 
Aug; 14(1):9-20). 
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4.5 Imaging studies 
Structural changes in the pancreas and its ductal system are only seen during the moderate 
and severe stages of the disease, so most imaging procedures cannot depict early chronic 
pancreatitis. 
4.5.1 Abdominal radiograph 
Pancreatic calcification is observed in 30% of cases. They first form in the head and then in 
body and tail. Paired anterposterior and oblique views are preferred because the vertebral 
column may otherwise obscure small specks of calcification. 
4.5.2 Computerized tomography 
Although CT excels at depicting the morphological changes of advanced chronic 
pancreatitis, the early changes are beyond its resolution and a normal finding on this study 
does not rule out chronic pancreatitis. CT is most useful to identify complications and in 
planning surgical or endoscopic intervention (Yashke P, e-medicine). 
4.5.3 Endoscopic retrograde pancreatography (ERCP) 
ERCP provides the most accurate visualization of the pancreatic ductal system and has been 
regarded as the criterion standard for diagnosing chronic pancreatitis. Conversely one 
limitation of ERCP is that it cannot be used to evaluate the pancreatic parenchyma, and 
histologically proven chronic pancreatitis has been documented in the setting of normal 
pancreatogram. The pancreatogram can be classified according to several schemes such as 
Cambridge criteria (Laukisch etal.Pancreas 1996 Mar;12(2):149-52). 
A comparison of pancreatogram scoring with direct pancreatic function tests demonstrates 
good correlation. However, pancreatography tended to show more significant severe 
changes. ERCP is invasive, expensive, requires complete opacification of the pancreatic duct 
to visualize side branches and carries a risk of pancreatitis (Yashke P, e-medicine; Catalano 
MF et al. Gastrointestinal Endoscop 1998 Jul;48(1):11-7(medline). 
4.5.4 Magnetic resonance cholangiopancreatography (MRCP) 
MRCP imaging provides information on the pancreatic parenchyma and adjacent 
abdominal viscera and uses heavily T2 weighted images to visualize the biliary and 
pancreatic ductal system. The use of secretin during the procedure enhances the quality to 
enable the diagnosis of early chronic pancreatitis; however, it is relatively safe, reasonably 
accurate, non-invasive, fast and very useful in planning surgical and endoscopic 
intervention (Yashke P, e-medicine; Sota JA et al. AJR Am J Roentgenol 1995;165(6):1397-
401(medline). 
4.5.5 Endoscopic ultrasound (EUS) 
EUS may be the best test for imaging the pancreas as per the recent studies. By placing the 
transducer immediately adjacent to the pancreas, the endoscopic approach eliminates the 
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interference by bowel gas and enables the use of high frequency probes to enable acquisition 
of detailed imaging. Eleven sonographic criteria have been developed that identify 
characteristic findings of chronic pancreatitis. Using these criteria EUS correlates well with 
endoscopic pancreatic ductography and intra-ductal secretin tests in moderate and severe 
disease. EUS may be useful in diagnosing chronic pancreatitis in a subset of patient with 
non-ulcer dyspepsia. More experience is required to determine its utility in detecting the 
early stages of chronic pancreatitis (Yashke P, e-medicine; Catalano MF et al. Gastrointestinal 
Endoscop 1998 Jul;48(1):11-7(medline). The new Rosemont criteria, using a combination of 
major and/or minor criteria, categorizes the patient as having EUS features that are (1) 
consistent with chronic pancreatitis, (2) suggestive of chronic pancreatitis, (3) indeterminate 
of chronic pancreatitis, (4) normal. 
The researchers concluded that the new Rosemont classification system represents an 
improvement over current means of EUS diagnosis for chronic pancreatitis. They 
acknowledge the results of their deliberations do not provide a validation of their 
recommendations, but intend to apply these criteria in a manner that provides easy and 
reproducible means of EUS diagnosis and grading of chronic pancreatitis so that they may 
be used to help guide patient care and future study design. In an accompanying editorial, 
Walter G. Park, MD, and ASGE President Jacques Van Dam, MD, PhD, FASGE, division of 
gastroenterology, Stanford University Medical Center, Cal., state that "despite being less 
than the perfect criterion standard, it remains the best to date"(EUS-Based Criteria For The 
Diagnosis Of Chronic Pancreatitis: The Rosemont Classification,ScienceDaily (June 29, 2009) 
American Society for Gastrointestinal Endoscopy). 
4.6 Other tests 
A secretin stimulated ultrasound study is one way of looking for the resistance to pancreatic 
juice outflow at the level of the duodenum. The diameter of the pancreatic duct is measured 
at baseline and then 15 and 30 min after injection of secretin. Dilatation to a diameter greater 
than normal or for a longer period implies the presence of periampullary stricture or 
papillary stenosis (Yashke P,e-medicine; Catalano MF et al. Gastrointestinal Endoscop 1998 
Jul;48(1):11-7(medline). 
5. What is the most appropriate procedure? 
The choice of surgical procedure depends upon the indication for surgery and the 
characteristics of disease in the individual patient. In general it is most appropriate to 
select a procedure which is likely to achieve the maximum symptomatic pain relief and 
also maximally preserve the functional pancreatic tissue.(Wani NA et al. Int J Surg 
2007;5:45-56). 
Drainage procedures were developed on the basis that the pain in chronic pancreatitis is due 
to ductal hypertension (Ebbehoj N et al.Scand J Gastroenterol 1984;19:1066-8) and proper 
drainage could decompress it. On the other hand the theories of perineural inflammation as 
the cause of pain lead to the development of resectional procedures (Bockmann DE. 
Gastroenterology 1988;94;1459-69). 
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5.1 Drainage procedure 
1. Partial: draining the duct partially, 
a. Sphincterotomy and sphincteroplasty, 
b. Duval procedure, 
c. Puestow Gillesby procedure, 
d. Leger’s procedure, 
e. Marcadier procedure, 
2. Complete: draining the main duct completely, 
I. Pancreaticojejunostomy, 
a. PartingtonRochelle procedure, 
b. Bapat’s modification of Partington’s procedure, 
II. Pancreaticogastrostomy, 
a. Moreno Gonzales procedure. 
5.2 Resectional procedures 
a. Whipple’s operation, 
b. Traversoe Longmire procedure, 
c. Begar’s procedure, 
d. Berne modification, 
e. Denervated pancreatic flap, 
Warrens denervated pancreatic flap, 
Shires denervated splenopancreatic flap, 
f. Subtotal pancreatic resection, 
g. Childs procedure, 
h. Total pancreatectomy, 
With duodenal preservation, 
Without duodenal preservation. 
5.3 Extended drainage procedure 
a. Rumpf’s extended drainage. 
5.4 Resection with extended drainage 
a. Extended Begar’s procedure, 
b. Frey’s procedure, 
c. Izbicki V shaped ventral pancreatic excision. 
5.5 Pancreatic denervation alone 
a. Left splanchnicectomy with celiac ganglionectomy, 
b. Left splanchnicectomy, celiac ganglionectomy with bilateral vagotomy, 
c. Complete pancreatic denervation, 
d. Transthoracic /videothoracoscopic pancreatic denervation: 
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5.6 Pancreatic auto-transplantation 
a. Islet cell transplantation, 
b. Segmental pancreatic transplantation. 
Drainage procedures 
These drainage procedures gave pain relief in up to 60-80% cases (Udani PM et 
al<http/bhjorg/journal /1999: 4102>). 
Partial drainage procedures 
Sphincterotomy and sphincteroplasty 
Transduodenal sphincterotomy was originally proposed by Doubilet and Mulholland for the 
treatmentof chronic pancreatitis with the mistaken belief that the disease was caused by bile 
reflux (Doubilet H et al. J Am Med Assoc 1956;160:521-8).The operation did not prove effective 
and subsequent attempts to improve pancreatic drainage by dividing the septum between the 
bile duct and the pancreatic duct have not proved popular (Bartlet MK et al.New Engl J Med 
1960;262:642-8). In chronic pancreatitis it is unusual to find a uniformly dilated duct obstructed 
at the termination only therefore it follows that these procedures are unlikely to prove 
successful; however, early success rates of 50% (Doubilet H et al. J Am Med Assoc 
1956;160:521-8 Bartlet MK et al. New Engl J Med 1960;262:642-8) when pain relief was assessed 
at 5 years have not been sustained (Bagley FH et al.Am J Surg 1981;141:418-21) Although 
surgical sphincterotomy has largely been given up; similar procedures have been performed 
endoscopically in the past with enthusiasm (Grim H et al.Endoscopy 1989;21:70-4). 
Duval procedure 
Decompression of the main pancreatic duct is achieved by resection of the pancreatic tail 
and retrograde drainage of the pancreatic duct via a termino-lateral pancreaticojejunostomy 
(Figure 1). 
 
Fig. 1. Duval Procedure 
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However, this procedure will only be effective if there is a single stricture between 
pancreatic tail and the ampulla of Vater which in most of the cases is unlikely (Duval MK. 
Ann Surg 1954;140:775-85). 
Puestow Gillesby procedure 
They recommend a longitudinal opening of the pancreatic duct from the site of the 
transaction of the duct after resection of the pancreatic tail and spleen to a point to the right 
of the mesenteric vessels and invagination of the open duct with pancreas into a Roux-en-Y 
loop of jejunum, thus ensuring a wider drainage of the ductal system. This procedure takes 
care of multiple strictures seen in chronic pancreatitis (Puestow CB et al. Arch Surg 
1958;76:898-906). 
 
Fig. 2. Puestow Gillsby Procedure 
Leger’s procedure 
This procedure developed for distal strictures involves a 40% distal pancreatectomy with 
splenectomy followed by opening of the pancreatic duct into a loop of jejunum by a 
retrograde lateral pancreaticojejunostomy (Leger L et al. Ann Surg 1974;180:180-91). 
Mercadier procedure 
Here only the body of the pancreas is drained into a Roux-en-Y loop of jejunum by a side to 
side anastamosis (Udani PM et al<http/bhjorg/journal/1999:4102>). 
Partial drainage procedures have been abandoned because of the small anastamosis which 
tends to occlude. Also the concept of preservation of the spleen with pancreatic tail is 
important as it prevents post-splenectomy sepsis(Govil S et al. Br J Surg 1999;86(7):895-8) 
and delays the onset of diabetes mellitus (Withigen J et al. Ann Surg 1974;179:412-8). 
Complete drainage procedures 
Pancreaticojejunostomy 
Partington Rochelle procedure. This procedure is a refined Puestow procedure. It consists 
of a side to side long pancreaticojejunostomy, at least 10 cm without, resection of the 
pancreatic tail or the pancreas. However, a dilated main pancreatic duct (minimum 8 mm) is 
a prerequisite for a good duct to mucosa anastamosis (Partington RF et al. Ann Surg 
1960;152:1037-42). In one of the largest series Greenlee (Grenlee HB et al. World J Surg 
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1990;14:70-6) reported significant improvement in 82% of there patients with lateral 
pancreaticojejunostomy with an extended follow up of up to 25 years. Similar results have 
been reported by others (Leger L et al. Ann Surg 1974;180:180-91;Moreno-Gonzales I et al. Br 
J Surg 1982;69:254). In our experience, this procedure has been performed on more than 130 
patients of chronic pancreatitis with a duct size of more than 7 mm since 1985 till date. We 
strongly are in favour of this procedure in any patient with a duct size of more than 7 mm 
because of the technical ease, low morbidity, and excellent long-term results. We observed 
significant long-term improvement in more than 80% of our patients operated at Sher-i-
Kashmir Institute of Medical Sciences,Srinagar,Jammu and Kashmir,India. 
 
Fig. 3. The Partington Rochelle procedure 
Bapat’s procedure. It is modification of Partington’s procedure. Here the pancreatic duct is 
opened from head to tail with wide drainage by a side to end pancreaticojejunostomy after 
fish mouthing the jejunal end to a required length. A duct to mucosa anastamosis is 
performed. Again the prerequisite is a dilated duct of at least 7 mm. This procedure is more 
physiological and ensures a straight conical dependent anastamosis with effective and 
complete drainage (Bapat RD. Indian J Gastroenterol 1997 Jul;16(3):119-20). 
Pancreaticogastrostomy 
Pancreaticogastrostomy has been advocated by some to be a better form of drainage 
procedure than pancreaticojejunostomy (Pain JA et al. Br J Surg 1988;75:220-22). The 
procedure is performed as a mucosa to mucosa anastamosis over a T tube. A pain relief of 
up to 79% has been reported (Jordan GL et al. Am J Surg 1977;133:46-50); however, more 
patients developed steatorrhoea because of the inactivation of the pancreatic enzymes by 
gastric acid. However,most surgeons still regard pancreaticojejunostomy as the drainage 
operation of choice. 
Moreno Gonzales procedure  
Pancreatic and bile duct drainage is established into an isolated vascularised loop of 
jejunum which is then anastamosed to the duodenum. The procedure has potential 
advantages, it allows the return of bile and pancreatic secretions into the duodenum and 
there is no pancreaticocibal asynchrony. 
In conclusion the patients with ductal dilatation of more than 7-8 mm, no inflammatory 
mass or ductal abnormality in the head and uncinate process are the most suitable 
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candidates for lateral pancreaticojejunostomy. The results of pancreaticojejunostomy are 
difficult to interpret. Many reports have differing indications, different forms of surgery and 
inadequate follow up. In general however, all forms of drainage procedures tend to worsen 
over time especially if patients do not abstain from alcohol (Lerut JP et al. Ann Surg 
1984;1999:432-7). 
Resectional procedure 
The head is considered to be pacemaker of the disease and its complications. A mass in the 
pancreatic head is found in 30-60% of the patients with chronic pancreatitis (Buchler M et al. 
Am J Surg 1995;169:65-70). No study has yet conclusively shown pain being only 
attributable to main duct obstruction and it is difficult to think of a good reason to believe 
so. The pathogenesis of pain is most likely not only related to ductal and parenchymal 
hypertension but also to the theory of perineural inflammation (Bockmann DE. 
Gastroenterology 1988;94:1459-69). 
In addition lateral pancreaticojejunostomy never drains the second and third order 
pancreatic ducts, hence the concept led to the development of resectional procedures. 
Whipple’s operation (1935) 
The procedure although first described by Allen O Whipple in 1912, but published much 
later for malignant lesions of the head of the pancreas is now also used for benign 
inflammatory mass in the head with a non-dilated pancreatic duct. The procedure consists 
of a pancreaticoduodenectomy with reconstruction by a pancreaticojejunostomy/ 
gastrostomy, gastrojejunostomy and choledochojejunostomy. The intellectual basis for the 
shift in resection of the distal pancreas to that of pancreatic head was the concept of the 
”Pain Pacemaker” being located in the head of the pancreas promulgated by Dr. Longmires. 
This is a complex and technically challenging procedure with higher mortality rates as 
compared to drainage procedure, however, with good results. This procedure involves 
excising normal organs much against the principles of surgery for a benign disorder and has 
given way to more conservative approaches (Augusto JB et al. The Pancreas) However, it is 
the preferred surgical option if there is any suspicion of malignancy, as in such a situation 
there should be no compromise on the radicality of the procedure. 
Traversoe Longmire procedure 
Originally used in 1994 for a peri-ampullary tumor by Watson(Watson K. Br J Surg 
1944;31:368-73) it was subsequently used by Traversoe Longmire for chronic pancreatitis in 
1978 (Traverso and Longmire. Surg Gynecol Obstet 1978;156:581-6). As a gastrectomy is 
avoided and the pylorus and the proximal duodenum are preserved it achieves a better 
postoperative nutritional status, minimizes postgastrectomy syndromes as well as the 
incidence of marginal ulceration. For these reasons it has almost become the form of 
resection for patients requiring pancreaticoduodenectomy in chronic pancreatitis. Recent 
reports on pancreaticoduodenectomy for chronic pancreatitis have recorded a low mortality 
rate of 0-1%, significant pain relief of 80-100% (Traverso LW et al. Ann Surg 1997;226:429-38). 
The incidence of diabetes increased from 17 to 44% in the preoperative period to 26-64% in 
the postoperative period (Traverso LW et al. Ann Surg 1997;226:429-38;Rossi RL et al. Arch 
Surg 1987;122:416-20). However, the onset of diabetes on follow up rather than immediately 
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after the surgery suggests progression of the disease rather than the effect of surgery.The 
procedure got more established after the results of a randomized trial. Two hundred and 
fourteen patients were randomized to undergo either a standard or a pylorus-preserving 
Whipple resection. After exclusion of 84 patients on the basis of intraoperative findings, 130 
patients (66 standard Whipple operation and 64 pylorus-preserving resection) were entered 
into the trial. Of these, 110 patients with proven adenocarcinoma (57 standard Whipple and 
53 pylorus-preserving resection) were analysed for long-term survival and quality of life. 
There was no difference in perioperative morbidity. Long-term survival, quality of life and 
weight gain were identical after a median follow-up of 63·1 (range 4–93) months. At 6 
months, capacity to work was better after the pylorus-preserving procedure (77 versus 56 per 
cent; P = 0·019).The conclusion was that both procedures are equally effective for the 
treatment of pancreatic and periampullary cancer. Pylorus-preserving Whipple resection 
offers some minor advantages in the early postoperative period, but not in the long term. 
The same principle applies to managing chronic pancreatitis by using either of the 
procedure (Seiler, CA etal. British Journal of Surgery, May 2005;  92,( 5):  547–556). 
Hans Begar’s procedure 
This procedure is indicated in chronic pancreatitis with inflammatory mass in the head with 
medically intractable pain, obstruction of the common bile duct, duodenal stenosis or portal 
hypertension due to compression of portal vein by inflammatory mass. It is a duodenum 
sparing resection of the head of the pancreas thus preserving duodenal physiology and 
normal intestinal continuity which has significance in terms of postoperative nutritional 
status, blood sugar control and marginal ulceration. Two major steps are involved: 
Resection: The pancreas is transected at the border between the head and the body above 
the superior mesenteric vein leaving a small disk of the head between the common bile duct 
and the duodenal wall. 
Drainage: The body of the pancreas is drained by an end to end pancreaticojejunostomy and 
the pancreatic head by a side to side anastamosis to the rim of the resection cavity (Yasuda 
H et al. J Biliary Tract Pancreas 1990;11:967-73). The procedure seems to be safe with 
perioperative mortality of 0-0.8%. Significant relief of pain has been reported in 86-92% of 
patients. It is not associated with fresh development of diabetes in the early postoperative 
period. However, existing diabetes may worsen in 10-13% of the patients (Beger HG et al. 
Ann Surg 1999;230:512-23). Even, late diabetes develops in 21% of the patients due to 
progression of the disease. DPPHR when compared to PPPD has a superior outcome 
because of better pain control, weight gain, better glucose tolerance and higher insulin 
secretion capacity (Buchler M et al. Am J Surg 1995;169:65-70). 
Berne modification: In comparision to Begar’s technique this modification spares the 
dissection of the pancreatic body from the portal vein. After the resection of pancreatic head, 
a single cavum results which can be anastamosed end to side with a ROUX-en–Y jejunal 
loop. If stenosis of the intrapancreatic part of the common bile duct cannot be resolved by 
decompression and resection of the surrounding pancreatic tissue, or if the intrapancreatic 
portion of the common bile duct is opened accidentally during pancreatic head resection, 
the wall of the opened bile duct is fixed with single stitches to the surrounding tissues like 
an opened door and is included in the same anastamosis (Koninger J et al. Surgery 
2008;143(4):490-98). 
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Fig. 4. The Begar’s procedure 
 
Fig. 5. Berne modification 
Denervated pancreatic flaps 
In Warrens procedure the pancreas is divided over the portal superior mesenteric vein after 
ligation of the splenic artery and vein. The pancreatic head is excised leaving a thin rim. The 
remaining pancreas is not drained. Ligation of splenic vein and artery is presumed to 
denervate the gland (Warren WD et al. Surg Gynecol Obstet 1984;159:581-6). Shires et al 
described a more elaborate procedure called a denervated splenopancreatic flap for patients 
with small duct pancreatitis (Shires GT et al. Ann Surg 1986;203:568). The procedure 
includes complete mobilization of the pancreas from the retroperitoneum, resection of the 
head and the uncinate process leaving a small rim near the duodenum, division of the 
splenic vein near its junction with the superior mesenteric vein and drainage of the distal 
pancreatic remnant into a Roux-en-Y limb of jejunum. The complexity of the procedure and 
its unproven efficacy may limit its usefulness. 
Subtotal pancreatic resection 
Excision of the body and distal pancreas used to be a commonly performed procedure 
during 1960-1970 but with the development of better imaging facilities it was noted that 
disease in the body and the tail is often secondary to disease in the head of the pancreas, 
thereby limiting its role. This procedure is still indicated when the disease is confined to the 
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body and tail e.g., pseudocyst, failed pancreaticojejunostomy, non-dilated duct, pseudo-
aneurysm and when there is disease beyond the neck of pancreas, and the pancreatic duct is 
oversewn. A concomitant splenectomy is unavoidable in the majority of patients because of 
dense fibrosis precluding the isolation of the splenic vessels. However, splenic preservation 
may be possible in 20-34% of patients. Another procedure described by Warsaw in which 
splenic salvage is achieved by preservation of the short gastric vessels; early mortality is 0-
4% (Evans TD et al. Br J Surg 1997;84:624-9) and pain relief is 70-88% (Frey CF et al. Surg 
Clinc North Am 1989;69:499-528). About 20% develop diabetes in the early postoperative 
period. Severe hypoglycemic coma and brain damage occur in 2-4% of all such patients 
(Frey CF et al. Surgery of Pancreas 1997;347-55). Further an increased incidence of 
steatorrhoea is seen in 15% (Frey CF et al. Surg Clinc North Am 1989;69:499-528) 
Childs resection 
This procedure first described by Barret and Bowers in 1957(Barret O et al. USAF Med J 
1957;8:1037-41); was popularized by Child. It is a 95% distal pancreatectomy. The spleen, the 
tail, body and uncinate processes are completely removed. The small cuff of the head that is 
preserved protects the vascularity and common bile duct during surgery. This procedure is 
performed when lesser procedures have failed or when the entire pancreas is severely 
diseased (William JF et al. Ann Surg 1965;162(4):534-49). Pain relief is about 90% with a 
mortality of up to 4% while diabetes develops in 50% of patients (Frey CF et al. Surgery of 
Pancreas 1997;347-55) and the incidence of early steatorrhoea increases by 30% (Frey CF et 
al. Surg Clinc North Am 1989;69:499-528). 
Total pancreatectomy 
Total pancreatectomy bringing in its wake permanent endocrine and exocrine deficiency is 
usually offered as a last resort to patients with chronic pancreatitis who have diffuse 
involvement of the pancreas with non-dilated ducts, suspicion of malignancy or failed 
previous procedure. The operative mortality ranges from 0 to 10% and pain relief is 
achieved in 80% (Frey CF et al. Surg Clinc North Am 1989;69:499-528). In the absence of 
counter regulatory hormones control of sugar is very difficult (brittle diabetes). 
Hypoglycemic attacks after total pancreatectomy can lead to death or irreversible brain 
damage. Patients who are already insulin dependent and need pancreatic supplementation 
for steatorrhoea are ideally suited for this procedure. 
Duodenum preserving total pancreatectomy 
Russel in 1987 reported a total pancreatectomy with duodenal preservation. The operative 
procedure is extremely tedious; pain relief is achieved in 75-80% of patients and no 
postoperative deaths have been reported. Early complications include bleeding, sepsis and 
duodenal fistula. However, at a later stage patients may develop bile duct or duodenal 
stricture. This procedure is also offered as a last report as is total pancreatectomy (Easter 
DW et al. Ann Surg 1991;214:575-80). 
Extended drainage procedures 
Rumpf’s extended drainage procedure 
This is a combination of Partington’s procedure with a transduodenal pancreatic 
sphincteroplasty. It is indicated when there is a pre-papillary obstruction to the drainage of 
pancreatic duct due to stones or stricture (Rumpf KD et al. Chirurg 1983;54:722-7). 
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Resection with extended drainage 
The reported incidence of inflammatory mass in the head is about 30% of which only 10% are 
malignant (Marcus WB et al. Am J Surg.1995;169:65-70). Resection with extended drainage 
procedure provides cure in up to 95% of cases (Izbicki JR et al.Ann Surg 1995;221(4):350-8). 
Extended Begar’s procedure 
In cases where there are multiple strictures in the left pancreas with an inflammatory mass 
in the head, this procedure has a superior result. In addition to the duodenum preserving 
head resection a side to side pancreaticojejunostomy is performed after slitting open the 
main pancreatic duct.  
 
Fig. 6. The Extended Begar’s procedure 
Frey’s procedure 
A modified procedure combines lateral pancreaticojejunostomy of Partington Rochelle with 
coring out of the pancreatic head overlying the ducts of Wirsung and Santorini and the 
uncinate process using a diathermy, keeping at least 5 mm pancreatic tissue posteriorly and 
medially. If the duct is less than 8 mm in size mucosa to capsule anastamosis is performed. 
This procedure is indicated for pain in chronic pancreatitis with its complications like 
pseudocyst, common bile duct obstruction, pancreatic ascites, fistulae and recurrent pain 
after lateral pancreaticojejunostomy. It is contraindicated in patients where cancer cannot be 
excluded (Frey CF. Adv Surg 1999;32:41-85). 
Izbicki’s ‘‘V’’ shaped ventral pancreatic excision 
In this procedure a long ‘‘V’’ shaped excision of ventral aspect of the pancreas is done with a 
lateral pancreaticojejunostomy by a mucosa to capsule anastamosis. This procedure drains 
the main as well as the second and third order ducts. This is an ideal procedure for small 
duct disease with a maximum diameter of the Wirsung’s duct less than 3 mm (Izbicki JR et 
al. Ann Surg 1998;227(2):213-14). 
Pancreatic denervation alone 
Splanchnic nerves and the sympathetic trunks indicate pain arising from the pancreas, 
extrahepatic biliary ducts and gastrointestinal tract from the level of the stomach to the 
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Fig. 7. Duodenum-preserving pancreatic head resection by Frey 
rectosigmoid. Interest in surgical neurectomy has progressed by the observation that fibers 
which mediate pancreatic pain interconnect only through the celiac and superior mesenteric 
plexus. Various methods of deneravation have been described like left splanchnicectomy with 
celiac ganglionectomy with or without vagotomy. Mallet Guy advocated an extra peritoneal 
approach through the 12th rib for left splanchnicectomy with celiac ganglionectomy (Mallet 
Guy PA. Am J Surg 1983;145:234). This is done after correcting the extra pancreatic pathology. 
In a 5-year follow up of these patients there was an 84% overall improvement. However, the 
failure rate was up to 31% in patients with diffuse pancreatic fibrosis and no discernable extra 
pancreatic cause (White TT et al. Am J Surg 1966;112:195). The role of vagal fibers in pancreatic 
pain is unclear. Generally however, bilateral vagotomy is considered to increase the 
completeness of pancreatic denervation. 
Complete pancreatic denervation 
Hirokawa described a more extensive denervation procedure, which includes freeing the 
pancreas from the posterior abdominal wall and resection of all postganglionic pancreatic 
nerve plexus including those surrounding the common hepatic and splenic arteries (Hiraoka 
T et al. Am J Surg 1986;152:459). Although there are only a small number of patients who 
have undergone the procedure and this follow up is short; this procedure may provide a 
reasonable alternative to extensive resection. 
Transthoracic/videothoracoscopic pancreatic denervation 
There are important thoracic anatomical considerations regarding the innervation to the 
pancreas. The greater splanchnic nerves are largely responsible for pain in supramesentric 
viscera and the nerve trunks lie above the level of the 10th thoracic vertebra and descend 
along the spine to end in the celiac plexus, similarly the lesser splanchnic plexus. 
Transthoracic denervation can be achieved by division of the splanchnic nerves with 
bilateral vagotomy performed through a left thoracotomy. A similar procedure is now 
performed using a videothoracoscopic technique (Makarewicz W et al. World J Surg 
2003;27:906-11). This minimally invasive procedure achieved results almost equal to those of 
major abdominal surgery. Follow up of 12 months demonstrated an improved quality of 
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life. This procedure may be considered for patients who do not meet the anatomic criteria 
for drainage and those who may not be candidates for major abdominal surgery. 
Pancreatic auto-transplantation 
Although subtotal and total pancreatectomies successfully alleviate the pain of chronic 
pancreatitis, patients develop troublesome insulin dependent diabetes mellitus. This can be 
overcome by auto-transplantation. 
Islet cell auto-transplantation 
The Mirkowitch technique which is used to prepare partially purified islets produces a fairly 
large volume of minced digested islet cell tissue which is then injected into a portal vein. 
Despite slow injection portal pressure is markedly raised several fold. Hinshaw et al. 
developed and tested a more sophisticated islet preparation technique. This technique 
produced a 5 ml tissue pellet containing 500,000-2000,000 islets for transplantation, no 
problems were noted with this preparation and the portal pressure remained essentially 
unchanged. Long-term success (insulin independence) with both these techniques is 
reported at 40-43% (Hinshaw DB et al. Am J Surg 1981;42:118). In recent years total 
pancreatectomy and islet autotransplantation are done for chronic pancreatitis with 
intractable pain when other treatment measures have failed, allowing insulin secretory 
capacity to be preserved, minimizing or preventing diabetes, while at the same time 
removing the root cause of the pain. Since the first case in 1977, several series have been 
published. Pain relief is obtained in most patients, and insulin independence preserved long 
term in about a third, with another third having sufficient beta cell function so that the 
surgical diabetes is mild. Islet autotransplantation has been done with partial or total 
pancreatectomy for benign and premalignant conditions. Islet autotransplantation should be 
used more widely to preserve beta cell mass in major pancreatic resections (Blondet JJ,et al. 
(2007), Surgical Clinics of North America, 87(6): 1477-1501). 
Segmental pancreatic transplantation 
This technique comprises auto-transplantation of the resected body and tail of the pancreas 
into the thigh following near total pancreatectomy. The splenic vessels are anastamosed to 
the femoral vessels. The divided end of the pancreas is closed and the duct is ligated or 
injected with synthetic polymers (e.g., prolamine or neoprene). Duct obliteration is thought 
to cause rapid and permanent atrophy of the exocrine pancreas and preserves endocrine 
function. However, others concluded that duct obliteration does not prevent relapse or 
progression of chronic pancreatitis in the preserved pancreatic segment. Internal drainage of 
the duct into a Roux-en-Y limb of jejunum has also been reported with good results. 
Technical success was achieved in up to 80% of patients with pain relief in 80% and insulin 
independence in 70% (Rossi RL et al. Ann Surg 1986;203:626). 
Laparoscopic pancreatic resection 
Laparoscopic resection of the pancreas is technically quite demanding and most of the 
surgeons may find it cumbersome and time consuming, hence their adoption has been 
limited. Although the operation is technically feasible, the benefit of the laparoscopic 
approach may not be as apparent as that of a less complex laparoscopic procedure (Gagner 
M et al. Surg Endosc 1994;8(5):408-10).Recent years have seen an increasing trend in the use 
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of laparoscopy for distal pancreatic resection with splenic preservation. In most studies it 
has been found that distal pancreas resection can be performed as a laparoscopic procedure, 
with the usual advantages that this techniques has for the patient. Optimal closure of the cut 
edge of the pancreas and the preservation of the spleen and its main vessels are the most 
important aspects of this operation (Uranues S,et al. The American Journal of Surgery, Aug 
2006;192(2):257-261). Of late surgeons have started comparing the results of robotic surgery 
versus laparoscopic surgery in pancreatitis which continues still to be in its infancy because 
of little evidence at present available in literature (Samuel M,et al ,Pancreas(Oct 2010); 39(7): 
1109-1111). 
6. Ruling out a malignant neoplasm 
There is evidence to suggest that chronic pancreatitis could predispose to pancreatic 
malignancy (Lowenfels AB et al. New England J Med 1993;328:1433-7). Studies show that the 
risk rises with duration from 1.8% at 10 years to 4% at 20 years and it has been speculated 
that it is due to the increased levels of growth factors(Kore M et al. Gut 1994;35:1468-73); 
another report showed a 6% malignant change of inflammatory head mass at 9 years follow 
up (Beger HG et al. Ann Surg 1999;230:512-23). Concomitant malignancy has been reported 
in 15-21% of patients undergoing surgery for chronic pancreatitis which may be detected at 
surgery or on follow up (Ramesh H. Br J Surg 1992;79:544-9). Differentiating a malignant 
neoplasm in the head of the pancreas from an inflammatory mass of chronic pancreatitis is a 
major challenge for the surgeon which needs to be addressed at the time of surgery. The 
head in chronic pancreatitis is hard and enlarged so the hope of detecting carcinoma by 
palpation is not possible and is only an illusion. A 15% error in sampling as well as 
interpretation makes frozen section an unreliable tool to exclude malignancy (Campanale 
RP et al. Arch Surg 1985;12:283-8). Therefore a high degree of suspicion is to be entertained 
in these patients. In such a situation only resection probably pancreaticoduodenectomy should 
be preferred as any lesser procedure may leave behind the lesion or cause tumor spillage. 
Frequently, there bypass procedures become necessary after lateral pancreaticojejunostomy. 
With pylorus preserving resections these additional procedures are not required. This safely 
and effectively combines the control of complications with the preservation of original 
anatomy and thus is a more physiological procedure. The relevance of segmental portal 
hypertension in a patient of chronic pancreatitis is poorly understood. Complications of 
segmental portal hypertension are rare and its presence should not influence the choice of 
operation. Complications such as internal fistula, pseudocysts, pancreatico-portal fistula, or 
pseudoaneurysm require an individualized approach. 
7. Conclusion 
In conclusion Chronic pancreatitis results from a combination of inherited or acquired 
genetic predispositions coupled with glandular injury secondary to ingested compounds 
such as ethanol, prior mechanical injury, or injury secondary to other significant illness. The 
disease process leads to fibrosis, which yields mass effect and obstructs ductal drainage. 
Chronic inflammatory changes result in pain syndromes caused by directly injuring nerves 
and through humoral release of pain neurotransmitters. Ductal obstruction causes 
conditions to persist that provide a positive feedback loop for continued glandular injury 
(Martin RF and Marion MD. Surg Clinc N Am 2007;87:1461-75). 
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The old controversy ‘‘resection or drainage’’ is probably now irrelevant. Both have 
established roles and probably best results are achieved by a combination of both. Chronic 
pancreatitis is such a complex and variegated disease that there is never a single procedure 
that would achieve goals in all patients. Therefore, it is important to understand that the 
choice of surgery has to be individualized to address the pathological change in each 
patient. However, ultimately it is the surgeons experience and an operative strategy that is 
slightly modified for every patient that is going to achieve the best possible results and which 
is what would be ultimately an ideal or somewhat close to ideal procedure for chronic 
pancreatitis. However, most of the operative procedures described in this monogram need a 
larger series of treated patients to be followed to adopt a definitive and probably better 
future strategy for managing this complex problem. However, the good news for a 
pancreatic surgeon is that operative management can be performed with low mortality and 
acceptable morbidity. Surgical treatment can provide good pain control, return patients to 
work, and achieve a satisfactory quality of life in the majority of patients. Longterm mortality 
is high in a subset of patients (Schnelldorfer T et al. J Am Coll Surg 2007;204:1039-1047). 
Latest literature suggests the role of oral pancreatic enzyme supplmentation and dietary 
modification in improving digestive tract function in people with chronic pancreatitis (The 
Medifocus Guidebook on Chronic Pancreatitis, 123 pages; last updated June 21, 2011). 
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